Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives
Author(s) -
Hamid Rashidzadeh,
Hossein Danafar,
Hossein Rahimi,
Faezeh Mozafari,
Marziyeh Salehiabar,
Mohammad Amin Rahmati,
Samaneh Rahamouz-Haghighi,
Navid Mousazadeh,
Ali Mohammadi,
Yavuz Nuri Ertaş,
Ali Ramazani,
Irada Huseynova,
Rovshan Khalilov,
Soodabeh Davaran,
Thomas J. Webster,
Taras Kavetskyy,
Aziz Eftekhari,
Hamed Nosrati,
Mehdi Mirsaeidi
Publication year - 2021
Publication title -
nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 109
eISSN - 1748-6963
pISSN - 1743-5889
DOI - 10.2217/nnm-2020-0441
Subject(s) - covid-19 , pandemic , coronavirus , medicine , intensive care medicine , nanotechnology , infectious disease (medical specialty) , disease , virology , pathology , materials science , outbreak
COVID-19, as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine has been approved yet for this pandemic disease. Cutting-edge tools, especially nanotechnology, should be strongly considered to tackle this virus. This review aims to propose several strategies to design and fabricate effective diagnostic and therapeutic agents against COVID-19 by the aid of nanotechnology. Polymeric, inorganic self-assembling materials and peptide-based nanoparticles are promising tools for battling COVID-19 as well as its rapid diagnosis. This review summarizes all of the exciting advances nanomaterials are making toward COVID-19 prevention, diagnosis and therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom